Profile
Cristina M.
Rondinone is currently Chief Executive Officer & Director at Pep2Tango Therapeutics, Inc. Formerly, served as Independent Director at Axcella Health, Inc. from 2018 to 2023, Senior Vice President-Research & Development at MedImmune LLC from 2011 to 2019, Associate Professor at the University of Gothenburg, and President at Cellarity Inc. from 2019 to 2020.
Education includes graduate and doctorate degrees from Universidad de Buenos Aires.
Cristina Rondinone active positions
| Companies | Position | Start |
|---|
Former positions of Cristina Rondinone
| Companies | Position | End |
|---|---|---|
| AXCA HEALPAR | Director/Board Member | 2023-10-31 |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | President | 2020-05-31 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 2019-08-31 |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Cristina Rondinone
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Universidad de Buenos Aires
Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
- Stock Market
- Insiders
- Cristina Rondinone
















